Amaia Lujambio
0000-0002-2798-1481
8 papers found
Refreshing results…
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Mouse models of oncoimmunology in hepatocellular carcinoma
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology
β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Hepatocellular carcinoma: killing one bird with two stones
Missing publications? Search for publications with a matching author name.